BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30525879)

  • 21. Severe reaction to radiotherapy provoked by hypomorphic germline mutations in ATM (ataxia-telangiectasia mutated gene).
    Asadollahi R; Britschgi C; Joset P; Oneda B; Schindler D; Meier UR; Rauch A
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1409. PubMed ID: 32748564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ataxia-telangiectasia (A-T): An emerging dimension of premature ageing.
    Shiloh Y; Lederman HM
    Ageing Res Rev; 2017 Jan; 33():76-88. PubMed ID: 27181190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel pathogenic variant in an Iranian Ataxia telangiectasia family revealed by next-generation sequencing followed by in silico analysis.
    Tabatabaiefar MA; Alipour P; Pourahmadiyan A; Fattahi N; Shariati L; Golchin N; Mohammadi-Asl J
    J Neurol Sci; 2017 Aug; 379():212-216. PubMed ID: 28716242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late-onset autosomal recessive cerebellar ataxia and neuropathy with a novel splicing mutation in the
    Shimazaki H; Kobayashi J; Sugaya R; Nakano I; Fujimoto S
    J Integr Neurosci; 2020 Mar; 19(1):125-129. PubMed ID: 32259893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics of ataxia-telangiectasia presenting dystonia as a main manifestation.
    Kim M; Kim AR; Park J; Kim JS; Ahn JH; Park WY; Kim NKD; Lee C; Kim NS; Cho JW; Youn J
    Clin Neurol Neurosurg; 2020 Dec; 199():106267. PubMed ID: 33080427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Class Switch Recombination Defect on the Phenotype of Ataxia-Telangiectasia Patients.
    Amirifar P; Mozdarani H; Yazdani R; Kiaei F; Moeini Shad T; Shahkarami S; Abolhassani H; Delavari S; Sohani M; Rezaei A; Hassanpour G; Akrami SM; Aghamohammadi A
    Immunol Invest; 2021 Feb; 50(2-3):201-215. PubMed ID: 32116070
    [No Abstract]   [Full Text] [Related]  

  • 27. Studying the cerebellar DNA damage response in the tissue culture dish.
    Tzur-Gilat A; Ziv Y; Mittelman L; Barzilai A; Shiloh Y
    Mech Ageing Dev; 2013 Oct; 134(10):496-505. PubMed ID: 23583690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted disruption of Ataxia-telangiectasia mutated gene in miniature pigs by somatic cell nuclear transfer.
    Kim YJ; Ahn KS; Kim M; Kim MJ; Park SM; Ryu J; Ahn JS; Heo SY; Kang JH; Choi YJ; Choi SJ; Shim H
    Biochem Biophys Res Commun; 2014 Oct; 452(4):901-5. PubMed ID: 25193705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ataxia-Telangiectasia Presenting as Cerebral Palsy and Recurrent Wheezing: A Case Report.
    Navratil M; Đuranović V; Nogalo B; Švigir A; Dumbović Dubravčić I; Turkalj M
    Am J Case Rep; 2015 Sep; 16():631-6. PubMed ID: 26380989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNA sequencing combining with whole exome sequencing reveals a compound heterozygous variant in ATM in a girl with atypical ataxia-telangiectasia.
    Gu C; Wang H; Shu J; Zheng J; Li D; Cai C; Zhang P
    Clin Chim Acta; 2021 Dec; 523():6-9. PubMed ID: 34453918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compound heterozygous variants including a novel copy number variation in a child with atypical ataxia-telangiectasia: a case report.
    Lee HY; Jang DH; Kim JW; Lee DW; Jang JH; Joo J
    BMC Med Genomics; 2021 Aug; 14(1):204. PubMed ID: 34404412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute lymphoblastic leukemia in early childhood as the presenting sign of ataxia-telangiectasia variant.
    Bielorai B; Fisher T; Waldman D; Lerenthal Y; Nissenkorn A; Tohami T; Marek D; Amariglio N; Toren A
    Pediatr Hematol Oncol; 2013 Sep; 30(6):574-82. PubMed ID: 23509889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do elevated serum IgM levels have to be included in probable diagnosis criteria of patients with ataxia-telangiectasia?
    Azarsiz E; Karaca NE; Gunaydin NC; Gulez N; Ozturk C; Aksu G; Genel F; Kutukculer N
    Int J Immunopathol Pharmacol; 2014; 27(3):421-7. PubMed ID: 25280033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The appropriateness of the mouse model for ataxia-telangiectasia: neurological defects but no neurodegeneration.
    Lavin MF
    DNA Repair (Amst); 2013 Aug; 12(8):612-9. PubMed ID: 23731731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiparametric cerebellar imaging and clinical phenotype in childhood ataxia telangiectasia.
    Dineen RA; Raschke F; McGlashan HL; Pszczolkowski S; Hack L; Cooper AD; Prasad M; Chow G; Whitehouse WP; Auer DP
    Neuroimage Clin; 2020; 25():102110. PubMed ID: 31855653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATM mutation spectrum in Russian children with ataxia-telangiectasia.
    Suspitsin E; Sokolenko A; Bizin I; Tumakova A; Guseva M; Sokolova N; Vakhlyarskaya S; Kondratenko I; Imyanitov E
    Eur J Med Genet; 2020 Jan; 63(1):103630. PubMed ID: 30772474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and immunological assessment of children with ataxia telangiectasia attending Sohag university hospital in Upper Egypt.
    Fahmy EM; Salama EH; El-Mokhtar MA; Sadek AA
    Egypt J Immunol; 2021 Oct; 28(4):272-281. PubMed ID: 34882376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysfunction of cerebellar microglia in Ataxia-telangiectasia.
    Levi H; Bar E; Cohen-Adiv S; Sweitat S; Kanner S; Galron R; Mitiagin Y; Barzilai A
    Glia; 2022 Mar; 70(3):536-557. PubMed ID: 34854502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA repair abnormalities leading to ataxia: shared neurological phenotypes and risk factors.
    Gilmore EC
    Neurogenetics; 2014 Oct; 15(4):217-28. PubMed ID: 25038946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel variant in ATM gene causes ataxia telangiectasia revealed by whole-exome sequencing.
    Alonazi NA; Hundallah KJ; Al Hashem AM; Mohamed S
    Neurosciences (Riyadh); 2018 Apr; 23(2):162-164. PubMed ID: 29664460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.